Research Article
[Retracted] Evaluation of Liquid Biopsy in Patients with HER2-Positive Breast Cancer
Table 2
Comparison of CTCs, primary tumor by HER2 status in patients.
| | Total | CTCs-HER2-positive (%) | CTCs-HER2-negative (%) |
| Primary-HER2 status | 198 | 158 (79.8%) | 40 (20.2%) | Positive | 158 | 65 (41.1%) | 93 (58.9%) | Negative | 40 | 18 (45.0%) | 22 (55.0%) |
|
|